Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.
Wang P, Liu L, Nair MS, Yin MT, Luo Y, Wang Q, Yuan T, Mori K, Solis AG, Yamashita M, Garg A, Purpura LJ, Laracy JC, Yu J, Joshua-Tor L, Sodroski J, Huang Y, Ho DD. Wang P, et al. Among authors: nair ms. Emerg Microbes Infect. 2020 Dec;9(1):2091-2093. doi: 10.1080/22221751.2020.1823890. Emerg Microbes Infect. 2020. PMID: 32930052 Free PMC article.
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization.
Wang P, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS, Mascola JR, Chang JY, Yin MT, Sobieszczyk M, Kyratsous CA, Shapiro L, Sheng Z, Nair MS, Huang Y, Ho DD. Wang P, et al. Among authors: nair ms. Res Sq [Preprint]. 2021 Jan 29:rs.3.rs-155394. doi: 10.21203/rs.3.rs-155394/v1. Res Sq. 2021. Update in: Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2 PMID: 33532763 Free PMC article. Updated. Preprint.
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7.
Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS, Mascola JR, Chang JY, Yin MT, Sobieszczyk M, Kyratsous CA, Shapiro L, Sheng Z, Huang Y, Ho DD. Wang P, et al. Among authors: nair ms. bioRxiv [Preprint]. 2021 Feb 12:2021.01.25.428137. doi: 10.1101/2021.01.25.428137. bioRxiv. 2021. Update in: Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2 PMID: 33532778 Free PMC article. Updated. Preprint.
Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York.
Annavajhala MK, Mohri H, Wang P, Nair M, Zucker JE, Sheng Z, Gomez-Simmonds A, Kelley AL, Tagliavia M, Huang Y, Bedford T, Ho DD, Uhlemann AC. Annavajhala MK, et al. medRxiv [Preprint]. 2021 Aug 4:2021.02.23.21252259. doi: 10.1101/2021.02.23.21252259. medRxiv. 2021. Update in: Nature. 2021 Sep;597(7878):703-708. doi: 10.1038/s41586-021-03908-2 PMID: 33655278 Free PMC article. Updated. Preprint.
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Wang P, Nair MS, Liu L, Iketani S, Luo Y, Guo Y, Wang M, Yu J, Zhang B, Kwong PD, Graham BS, Mascola JR, Chang JY, Yin MT, Sobieszczyk M, Kyratsous CA, Shapiro L, Sheng Z, Huang Y, Ho DD. Wang P, et al. Among authors: nair ms. Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8. Nature. 2021. PMID: 33684923
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors.
Iketani S, Forouhar F, Liu H, Hong SJ, Lin FY, Nair MS, Zask A, Huang Y, Xing L, Stockwell BR, Chavez A, Ho DD. Iketani S, et al. Among authors: nair ms. Nat Commun. 2021 Apr 1;12(1):2016. doi: 10.1038/s41467-021-22362-2. Nat Commun. 2021. PMID: 33795671 Free PMC article.
210 results